Inflammatory choroidal neovascularization.
OBJECTIVE
Choroidal neovascularization (CNV) can be a severe sight-threatening sequela, which can be secondary to both infectious and noninfectious uveitis. This review summarizes the different diseases associated with CNV, highlighting new treatment modalities and the possible strategies, which could be applied for the therapy of this occurrence.


RESULTS
Since CNV can often originate from posterior pole lesions and can be hard to identify, an accurate examination is mandatory in order to identify the correct diagnosis. In the majority of cases, fluorescein angiography (FA), indocyanine green angiography (ICGA) and optical coherence tomography (OCT) enable the determination of the clinical characteristics of the CNV. An infectious disease should be looked for to include a suitable therapy when available. The treatment strategy for CNV secondary to noninfectious uveal inflammations should be directed at controlling the inflammatory process. Systemic corticosteroids with or without immunosuppressive agents are indicated even when the CNV occurs with apparently inactive uveitis: Chronic subclinical inflammation can be the basis for the pathogenesis of CNV. Additional therapies aimed directly at the neovascular process, such as the intravitreal anti-Vascular Endothelial Growth Factor (VEGF) agents, are recommended particularly when the therapy shows an insufficient response.


CONCLUSIONS
CNV secondary to uveitis is a severe sequela leading to significant visual impairment. ICGA is mandatory in order to obtain relevant information about the choroidal status. Several therapeutic options have been considered, but no guidelines are provided at the moment. Moreover, the current data are still only based on case reports or small series. For such reasons, further trials are mandatory to validate the preliminary available results.
Neri
Piergiorgi
P
The Eye Clinic-Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi-Ancona.
Lettieri
Marta
M
Fortuna
Cinzia
C
Manoni
Mara
M
Giovannini
Alfonso
A
Ophthalmology. 1998 Jun;105(6):1032-7
9627653
Ocul Immunol Inflamm. 2006 Jun;14(3):171-9
16766401
Curr Eye Res. 1990;9 Suppl:75-84
2143464
Ophthalmology. 1986 Sep;93(9):1138-47
2433660
Arch Ophthalmol. 1984 Dec;102(12):1776-84
6508619
Am J Ophthalmol. 1987 Feb 15;103(2):131-6
3812615
Br J Ophthalmol. 2007 May;91(5):620-3
17202205
Int Ophthalmol Clin. 2000 Spring;40(2):111-26
10791260
Retina. 1992;12(2):108-12
1439240
Ophthalmologica. 1996;210(4):229-33
8841071
Ophthalmic Surg Lasers Imaging. 2003 May-Jun;34(3):212-4
12757096
Ophthalmology. 1987 Jul;94(7):780-4
2443889
Eye (Lond). 2006 Feb;20(2):265-8
15746950
Emerg Infect Dis. 2003 Jan;9(1):55-62
12533282
Am J Ophthalmol. 1981 Mar;91(3):318-22
6163361
Am J Ophthalmol. 1978 Oct;86(4):462-6
707591
J Am Optom Assoc. 1999 Apr;70(4):245-52
10457701
Ann Ophthalmol. 1987 Mar;19(3):112-5
3566033
Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):219-24
16019682
Am J Ophthalmol. 2008 Dec;146(6):851-5
18723143
Br J Ophthalmol. 1982 May;66(5):326-31
6176258
Retina. 2001;21(4):317-23
11508876
Nippon Ganka Gakkai Zasshi. 2000 Jun;104(6):431-6
10885278
Int Ophthalmol. 2010 Oct;30(5):583-90
19727566
Exp Eye Res. 2005 Jul;81(1):38-47
15978253
Jpn J Ophthalmol. 2000 Nov 1;44(6):697
11094210
Ophthalmology. 1996 Apr;103(4):606-17
8618760
Ophthalmology. 1997 Nov;104(11):1813-9
9373111
Am J Ophthalmol. 2001 May;131(5):599-606
11336934
Am J Ophthalmol. 2002 Nov;134(5):790-2
12429271
Int Ophthalmol. 2009 Apr;29(2):67-74
17486298
Int Ophthalmol. 1996-1997;20(4):171-9
9112183
Arch Ophthalmol. 1987 Sep;105(9):1237-42
3632442
Arch Ophthalmol. 1986 Apr;104(4):503-12
2420315
Br J Ophthalmol. 2005 Feb;89(2):147-50
15665342
Br J Ophthalmol. 1974 Sep;58(9):784-97
4433492
Ophthalmology. 1996 Jul;103(7):1100-5
8684800
Am J Ophthalmol. 1998 Jul;126(1):59-69
9683150
Retina. 1994;14(3):256-9
7526431
Am J Ophthalmol. 1993 Apr 15;115(4):517-23
8470726
Ann Ophthalmol. 1989 Jun;21(6):225-9
2475047
Am J Ophthalmol. 1985 Jan 15;99(1):40-4
2578252
Eur J Ophthalmol. 1996 Jul-Sep;6(3):299-306
8908438
JAMA. 1994 Jan 26;271(4):304-7
8295291
Transplantation. 2004 Aug 15;78(3):338-44
15316360
Arch Ophthalmol. 1988 Oct;106(10):1439-43
2460072
Am J Ophthalmol. 1978 Jan;85(1):82-7
619689
Arch Ophthalmol. 1982 Nov;100(11):1773-5
6182866
Arch Ophthalmol. 1998 Nov;116(11):1456-61
9823346
Bull World Health Organ. 1994;72(2):213-20
8205640
Am J Ophthalmol. 1976 Sep;82(3):343-51
961787
Arch Ophthalmol. 1998 Feb;116(2):249-50
9488284
Eye (Lond). 1998;12 ( Pt 2):266-72
9683952
Transplant Proc. 2004 Jun;36(5):1372-6
15251335
Graefes Arch Clin Exp Ophthalmol. 2008 Dec;246(12):1685-92
18682970
Int Ophthalmol. 2008 Aug;28(4):311-6
18401552
Int Ophthalmol. 2010 Feb;30(1):51-6
19183856
Am J Ophthalmol. 1995 Sep;120(3):291-301
7661200
JAMA. 1999 Aug 18;282(7):677-86
10517722
Am J Transplant. 2003 Dec;3(12):1550-9
14629285
Ophthalmology. 1985 Aug;92(8):1035-46
2413415
Eur J Ophthalmol. 2007 Nov-Dec;17(6):996-9
18050132
Eye (Lond). 1995;9 ( Pt 1):42-7
7713249
Br J Ophthalmol. 2005 Sep;89(9):1109-11
16113360
Am J Ophthalmol. 1984 Nov;98(5):572-84
6208783
Ophthalmic Surg Lasers Imaging. 2006 May-Jun;37(3):240-2
16749263
Ophthalmology. 2008 Mar;115(3):540-545.e5
17988741
Klin Monbl Augenheilkd. 2004 Dec;221(12):1051-3
15599812
Surv Ophthalmol. 2003 May-Jun;48(3):257-93
12745003
Am J Ophthalmol. 1973 Nov;76(5):758-62
4748195
Am J Ophthalmol. 1979 Oct;88(4):683-9
92200
FASEB J. 2006 Mar;20(3):550-2
16423878
Br J Ophthalmol. 2007 Jun;91(6):773-80
17135336